Phibro Animal Health (NASDAQ:PAHC) Releases Earnings Results, Beats Expectations By $0.14 EPS

Phibro Animal Health (NASDAQ:PAHC) released its quarterly earnings results on Wednesday. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14, Zacks reports. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. Phibro Animal Health updated its FY 2025 guidance to 1.870-2.010 EPS.

Phibro Animal Health Price Performance

Shares of PAHC traded up $0.35 during trading hours on Wednesday, hitting $22.37. 149,110 shares of the company were exchanged, compared to its average volume of 141,187. The firm has a fifty day simple moving average of $21.89 and a 200-day simple moving average of $21.60. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The company has a market capitalization of $905.99 million, a PE ratio of 52.02, a PEG ratio of 0.56 and a beta of 0.52. Phibro Animal Health has a one year low of $10.03 and a one year high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date of this dividend is Wednesday, March 5th. Phibro Animal Health’s payout ratio is 111.63%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Morgan Stanley boosted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, January 29th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.